Cargando…
Protocol for the VAL-MAP 2.0 trial: a multicentre, single-arm, phase III trial to evaluate the effectiveness of virtual-assisted lung mapping by bronchoscopic dye injection and microcoil implementation in patients with small pulmonary nodules in Japan
INTRODUCTION: Tumour localisation is important for successful resection of lung nodules with optimal resection margins in sublobar resection. Virtual-assisted bronchoscopic localisation technique combined with dye marking and microcoil placement (VAL-MAP 2.0) is a minimally invasive, virtual-assiste...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731790/ https://www.ncbi.nlm.nih.gov/pubmed/31488472 http://dx.doi.org/10.1136/bmjopen-2018-028018 |
_version_ | 1783449732073390080 |
---|---|
author | Ueda, Keiko Uemura, Yukari Sato, Masaaki |
author_facet | Ueda, Keiko Uemura, Yukari Sato, Masaaki |
author_sort | Ueda, Keiko |
collection | PubMed |
description | INTRODUCTION: Tumour localisation is important for successful resection of lung nodules with optimal resection margins in sublobar resection. Virtual-assisted bronchoscopic localisation technique combined with dye marking and microcoil placement (VAL-MAP 2.0) is a minimally invasive, virtual-assisted, bronchoscopic technique that combines dye marking and microcoil implementation. As indwelling microcoils can provide information on the depth from the lung surface, they can be applied for deeply located small lung tumours that are barely identifiable by surface dye marking. This proposed study will examine the effectiveness of VAL-MAP 2.0 in patients with small pulmonary nodules. METHODS AND ANALYSIS: This is a multicentre, prospective, single-arm, clinical trial. A total of 65 patients will be registered to undergo VAL-MAP 2.0 followed by thoracoscopic surgery. The primary outcome is successful resection, defined as resection of the lesion with optimal resection margins. The goal of the study is the achievement of a successful resection rate of 80%. ETHICS AND DISSEMINATION: The study was approved by the Clinical Research Review Boards of the University of Tokyo (approval number 218 003SP) for all institutes, and the Technical Review Board for Advanced Medicine Category B of the Ministry of Health, Labour and Welfare. Results of the primary and secondary endpoints will be submitted for publication in a peer-reviewed journal. TRIAL REGISTRATION NUMBER: jRCTs031180099 |
format | Online Article Text |
id | pubmed-6731790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-67317902019-09-20 Protocol for the VAL-MAP 2.0 trial: a multicentre, single-arm, phase III trial to evaluate the effectiveness of virtual-assisted lung mapping by bronchoscopic dye injection and microcoil implementation in patients with small pulmonary nodules in Japan Ueda, Keiko Uemura, Yukari Sato, Masaaki BMJ Open Surgery INTRODUCTION: Tumour localisation is important for successful resection of lung nodules with optimal resection margins in sublobar resection. Virtual-assisted bronchoscopic localisation technique combined with dye marking and microcoil placement (VAL-MAP 2.0) is a minimally invasive, virtual-assisted, bronchoscopic technique that combines dye marking and microcoil implementation. As indwelling microcoils can provide information on the depth from the lung surface, they can be applied for deeply located small lung tumours that are barely identifiable by surface dye marking. This proposed study will examine the effectiveness of VAL-MAP 2.0 in patients with small pulmonary nodules. METHODS AND ANALYSIS: This is a multicentre, prospective, single-arm, clinical trial. A total of 65 patients will be registered to undergo VAL-MAP 2.0 followed by thoracoscopic surgery. The primary outcome is successful resection, defined as resection of the lesion with optimal resection margins. The goal of the study is the achievement of a successful resection rate of 80%. ETHICS AND DISSEMINATION: The study was approved by the Clinical Research Review Boards of the University of Tokyo (approval number 218 003SP) for all institutes, and the Technical Review Board for Advanced Medicine Category B of the Ministry of Health, Labour and Welfare. Results of the primary and secondary endpoints will be submitted for publication in a peer-reviewed journal. TRIAL REGISTRATION NUMBER: jRCTs031180099 BMJ Publishing Group 2019-09-04 /pmc/articles/PMC6731790/ /pubmed/31488472 http://dx.doi.org/10.1136/bmjopen-2018-028018 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Surgery Ueda, Keiko Uemura, Yukari Sato, Masaaki Protocol for the VAL-MAP 2.0 trial: a multicentre, single-arm, phase III trial to evaluate the effectiveness of virtual-assisted lung mapping by bronchoscopic dye injection and microcoil implementation in patients with small pulmonary nodules in Japan |
title | Protocol for the VAL-MAP 2.0 trial: a multicentre, single-arm, phase III trial to evaluate the effectiveness of virtual-assisted lung mapping by bronchoscopic dye injection and microcoil implementation in patients with small pulmonary nodules in Japan |
title_full | Protocol for the VAL-MAP 2.0 trial: a multicentre, single-arm, phase III trial to evaluate the effectiveness of virtual-assisted lung mapping by bronchoscopic dye injection and microcoil implementation in patients with small pulmonary nodules in Japan |
title_fullStr | Protocol for the VAL-MAP 2.0 trial: a multicentre, single-arm, phase III trial to evaluate the effectiveness of virtual-assisted lung mapping by bronchoscopic dye injection and microcoil implementation in patients with small pulmonary nodules in Japan |
title_full_unstemmed | Protocol for the VAL-MAP 2.0 trial: a multicentre, single-arm, phase III trial to evaluate the effectiveness of virtual-assisted lung mapping by bronchoscopic dye injection and microcoil implementation in patients with small pulmonary nodules in Japan |
title_short | Protocol for the VAL-MAP 2.0 trial: a multicentre, single-arm, phase III trial to evaluate the effectiveness of virtual-assisted lung mapping by bronchoscopic dye injection and microcoil implementation in patients with small pulmonary nodules in Japan |
title_sort | protocol for the val-map 2.0 trial: a multicentre, single-arm, phase iii trial to evaluate the effectiveness of virtual-assisted lung mapping by bronchoscopic dye injection and microcoil implementation in patients with small pulmonary nodules in japan |
topic | Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731790/ https://www.ncbi.nlm.nih.gov/pubmed/31488472 http://dx.doi.org/10.1136/bmjopen-2018-028018 |
work_keys_str_mv | AT uedakeiko protocolforthevalmap20trialamulticentresinglearmphaseiiitrialtoevaluatetheeffectivenessofvirtualassistedlungmappingbybronchoscopicdyeinjectionandmicrocoilimplementationinpatientswithsmallpulmonarynodulesinjapan AT uemurayukari protocolforthevalmap20trialamulticentresinglearmphaseiiitrialtoevaluatetheeffectivenessofvirtualassistedlungmappingbybronchoscopicdyeinjectionandmicrocoilimplementationinpatientswithsmallpulmonarynodulesinjapan AT satomasaaki protocolforthevalmap20trialamulticentresinglearmphaseiiitrialtoevaluatetheeffectivenessofvirtualassistedlungmappingbybronchoscopicdyeinjectionandmicrocoilimplementationinpatientswithsmallpulmonarynodulesinjapan |